title: Catatonia associated with lorazepam withdrawal.
authors.affiliation: Department of Psychiatry, Atlanta VA Medical Center, Decatur, GA 30033, USA.
authors.forename: S G
authors.initials: SG
authors.lastname: Glover
authors.forename: R
authors.initials: R
authors.lastname: Escalona
authors.forename: J
authors.initials: J
authors.lastname: Bishop
authors.forename: A
authors.initials: A
authors.lastname: Saldivia
mesh_terms: D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002389:Catatonia / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008140:Lorazepam / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*
chemical_list: D014151:Anti-Anxiety Agents; D008140:Lorazepam